Literature DB >> 809612

Suppression of intracellular multiplication of Mycobacterium tuberculosis by virus-inhibiting factor or interferon.

K Mizunoe, M Hiraki, Y Nagano, N Maehara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 809612     DOI： 10.1111/j.1348-0421.1975.tb00875.x

Source DB:  PubMed          Journal:  Jpn J Microbiol        ISSN： 0021-5139


× No keyword cloud information.
  4 in total

1.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

2.  Studies on Brucella interferon: chromatographic behaviour and purification.

Authors:  C Bousquet-Ucla; J Wietzerbin; E Falcoff
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Tuberculosis endotypes to guide stratified host-directed therapy.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Sandra L Grimm; Larry S Schlesinger; Edward A Graviss; Jeffrey D Cirillo; Cristian Coarfa; Anna M Mandalakas; Jan Heyckendorf; Stefan H E Kaufmann; Christoph Lange; Mihai G Netea; Reinout Van Crevel
Journal:  Med (N Y)       Date:  2021-01-16

4.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.